Search

Philip J Rybczynski

from Dundalk, MD
Age ~64
Get Report
Also known as:
Philip J Rybcynski, Phillip J Rybcynski, Phillip Rybczynski, Philip J Rybcznski, Phill Rybcynski, Phil Rybczynski, Phil Rybcynski
Related to:
Douglas R Rybczynski, 29Clare G Rybczynski, 61
Connected to:
Caitlin M Rybczynski, 34Victoria J Rybenski, 45Andrea C Ryberg, 48Ariel E Ryberg, 33Kevin P Ryberg, 35Monica K Ryberg, 66Patricia L Ryberg, 84Shannon I Ryberg, 54Thomas C Ryberg, 64Katarzyna Rybicka, 42

Philip Rybczynski Phones & Addresses

  • Dundalk, MD
  • Philadelphia, PA
  • Branchburg, NJ
  • Somerville, NJ
  • Lebanon, NJ

Publications

Us Patents

Biologically Active 4H-Benzo [1,4]Oxazin-3-Ones

View page
US Patent:
6555536, Apr 29, 2003
Filed:
May 11, 2001
Appl. No.:
09/854302
Inventors:
Thomas P. Burris - Noblesville IN
Donald W. Combs - Neptune City NJ
Philip J. Rybczynski - Branchburg NJ
Assignee:
Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ
International Classification:
A61K 315377
US Classification:
5142305, 514 80, 544105
Abstract:
The invention is directed to 4h-benzo[1,4]oxazin-3-ones useful as peroxisome proliferator activated receptor gamma (PPAR) agonists or antagonists. Pharmaceutical compositions comprising compounds of the present invention and methods of treating conditions such as NIDDM and obesity are also disclosed.

Benzoxazinones As Peroxisome Proliferator Activated Receptor Gamma Modulators And Method Of Treatment

View page
US Patent:
6599899, Jul 29, 2003
Filed:
May 11, 2001
Appl. No.:
09/853798
Inventors:
Thomas P. Burris - Noblesville IN
Philip J. Rybczynski - Branchburg NJ
Assignee:
Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ
International Classification:
A61K 31536
US Classification:
5142305, 544105
Abstract:
The invention is directed to benzoxazinone derivatives useful as peroxisome proliferator activated receptor gamma (PPAR) modulators. Pharmaceutical compositions comprising compounds of the present invention and methods of treating conditions such as NIDDM and obesity are also disclosed.

Biologically Active 4H-Benzo [1,4] Oxazin-3-Ones

View page
US Patent:
6908908, Jun 21, 2005
Filed:
Nov 21, 2001
Appl. No.:
09/990461
Inventors:
Thomas P. Burris - Noblesville IN, US
Donald W. Combs - Neptune City NJ, US
Philip J. Rybczynski - Branchburg NJ, US
Joseph Dudash, Jr. - Hillsborough NJ, US
Assignee:
Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ
International Classification:
A61K031/538
C07D265/36
US Classification:
514 80, 5142305, 544105
Abstract:
The invention is directed to 4h-benzo[1,4]oxazin-3-ones useful as peroxisome proliferator activated receptor gamma (PPARĪ³) agonists or antagonists. Pharmaceutical compositions comprising compounds of the present invention and methods of treating conditions such as NIDDM and obesity are also disclosed.

Substituted Indazole-O-Glucosides

View page
US Patent:
7084124, Aug 1, 2006
Filed:
Jul 30, 2004
Appl. No.:
10/903034
Inventors:
Mona Patel - Belle Mead NJ, US
Philip J. Rybczynski - Branchburg NJ, US
Maud Urbanski - Flemington NJ, US
Xiaoyan Zhang - Belle Mead NJ, US
Assignee:
Janssen Pharmaceutica, N.V. - Beerse
International Classification:
A01N 43/04
A61K 31/70
C07H 15/00
C07H 17/00
US Classification:
514 27, 514 23, 514 25, 536 41, 536 172, 536 173, 536 174
Abstract:
Substituted indazole-O-glucosides, compositions containing them, and methods of using them, for example for the treatment of diabetes and Syndrome X are disclosed.

Substituted Fused Heterocyclic C-Glycosides

View page
US Patent:
7094763, Aug 22, 2006
Filed:
Jul 30, 2004
Appl. No.:
10/903136
Inventors:
Philip Rybczynski - Branchburg NJ, US
Maud Urbanski - Flemington NJ, US
Xiaoyan Zhang - Belle Mead NJ, US
Assignee:
Janssen Pharaceutica, N.V.
International Classification:
A01N 43/04
A61K 31/70
C07H 7/06
US Classification:
514 23, 514866, 514909, 536 111, 536 187, 536 292, 536 53, 536 54, 536 55
Abstract:
This invention relates to substituted fused heterocyclic C-glycosides, compositions containing them, and methods of using them, for example, for the treatment or prophylaxis of diabetes and Syndrome X.

Substituted Indole-O-Glucosides

View page
US Patent:
7129220, Oct 31, 2006
Filed:
Jul 30, 2004
Appl. No.:
10/903233
Inventors:
Mary Pat Beavers - New Hope PA, US
Mona Patel - Belle Mead NJ, US
Philip Rybczynski - Branchburg NJ, US
Maud Urbanski - Flemington NJ, US
Xiaoyan Zhang - Belle Mead NJ, US
Assignee:
Janssen Pharmaceutica N.V
International Classification:
A01N 43/04
A61K 31/70
C07H 15/00
C07H 17/00
US Classification:
514 27, 536 41, 536 172, 536 173, 536 174, 514 23, 514 25
Abstract:
Substituted indole-O-glucosides, compositions containing them, and methods of using them, for example for the treatment of diabetes and Syndrome X are disclosed.

Methods Of Using Substituted Tetralins And Indanes

View page
US Patent:
7351857, Apr 1, 2008
Filed:
Jun 3, 2005
Appl. No.:
11/145119
Inventors:
Xiaoli Chen - Belle Mead NJ, US
Keith T. Demarest - Flemington NJ, US
Jung Lee - Ambler PA, US
Jay M. Matthews - Lansdale PA, US
Philip Rybczynski - Branchburg NJ, US
Assignee:
Janssen Pharmaceutica N.V. - Beerse
International Classification:
C07C 241/00
C07C 315/00
A01N 37/12
US Classification:
562439, 514562, 514563, 562428
Abstract:
The invention features tetralin and indane compounds, compositions containing them, and methods of using them as PPAR alpha modulators to treat or inhibit the progression of, for example, diabetes.

Substituted Fused Heterocyclic C-Glycosides

View page
US Patent:
7482330, Jan 27, 2009
Filed:
Jun 15, 2006
Appl. No.:
11/453728
Inventors:
Philip Rybczynski - Branchburg NJ, US
Maud Urbanski - Flemington NJ, US
Xiaoyan Zhang - Belle Mead NJ, US
Assignee:
Janssen Pharmaceutica N.V. - Beerse
International Classification:
A01N 43/04
A61K 31/70
US Classification:
514 23, 514866, 514909
Abstract:
This invention relates to substituted fused heterocyclic C-glycosides, compositions containing them, and methods of using them, for example, for the treatment or prophylaxis of diabetes and Syndrome X.
Control profile
Philip J Rybczynski from Dundalk, MD, age ~64 Get Report